Douglas Elliman, Inc. (DOUG)

NYSEReal EstateReal Estate - ServicesSnapshot 2026-10-23

$1.59+6.00%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Douglas Elliman, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	265.2M
EPS	—	-0.02
Annual ending 2026-12-31
Revenue	—	1.04B
EPS	—	-0.23
Annual ending 2027-12-31
Revenue	—	1.11B
EPS	—	-0.19

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Positive cash flow from operations	Management aims to turn negative cash flow from operations of -$19.3M positive.	Improving	cash flow from operations remains negative next 4 quarters	Cash from operations: $11.603M FY2026-Q2; GAAP. Published target: cash flow from operations turns positive next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 10, 202611,603,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Operating loss improved from -$17.5M in 2026-Q1 to -$3.4M in 2026-Q2, and cash from operations turned positive from -$19.3M to $11.6M. Management's focus on expense discipline and AI-driven cost restructuring aligns with this improving cash flow trajectory, indicating delivering progress. Delivery assessment Oct 24, 2026
Management stability and execution improve	A supporting condition in Douglas Elliman, Inc.'s published investment case. The stated target is no major negative management or legal events next 4 quarters.	Under Pressure	new significant legal or management issues arise	1 new legal event (discrimination) vs 0 target News reports broker firing and racial discrimination allegations, creating reputational and legal risk. Context reviewed through Oct 24, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth reverses decline and stabilizes	A primary condition in Douglas Elliman, Inc.'s published investment case. The stated target is revenue stabilizes or grows to at least $214M next 4 quarters.	Intact	revenue falls below $214M next 4 quarters	Revenue: $283.449M FY2026-Q2; GAAP. Published target: revenue stabilizes or grows to at least $214M next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 10, 2026283,449,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 82b08699-8c6f-4660-8e10-07dab2faa45e. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Revenue grew 8.6% year over year on a comparable basis in 2026-Q2 from $271.4M to $283.4M, while 2026-Q1 revenue declined to $214.3M from $253.4M in 2025-Q1 due to a strong prior year quarter. Management's statements and revenue trajectory show delivering growth with some volatility due to market conditions. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-15	Unavailable	Unavailable	1 / 1
2026-10-16	Unavailable	Unavailable	1 / 1
2026-10-17	Unavailable	Unavailable	1 / 1
2026-10-18	Unavailable	Unavailable	1 / 1
2026-10-19	Unavailable	Unavailable	1 / 1
2026-10-20	Unavailable	Unavailable	1 / 1
2026-10-21	Unavailable	Unavailable	1 / 1
2026-10-22	Unavailable	Unavailable	1 / 1
2026-10-23	Unavailable	Unavailable	1 / 1
2026-10-24	Unavailable	Unavailable	1 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-10-01	0	1	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Positive cash flow from operationsCash from operations: $11.603M
Management stability and execution improvePublished status: Under Pressure
Revenue growth reverses decline and stabilizesRevenue: $283.449M

Next proof point

Nov 3, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.7%Typical daily move · historical

Downside history

-50.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Douglas Elliman, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a higher-risk, loss-making business with a watch-state multi-year view, not a proven compounder. Recent cash-flow progress is encouraging, but weak performance versus its industry cohort and volatile results leave execution unproven.

What's priced into Douglas Elliman, Inc.

The valuation evidence calls DOUG cheap versus peers, while the expectations gap is mildly negative, suggesting expectations are not especially demanding. The pricing tag is justified and fragility is low, but confidence in these assessments is medium; loss-making results also make valuation harder to judge.

What the fundamentals likely do

Near term, revenue growth may remain uneven: comparable revenue rose 8.6% year over year in the second quarter, while first-quarter revenue fell against a strong prior-year comparison. Operating cash flow turned positive in the second quarter and the operating loss narrowed, but the next results remain a risk given erratic earnings surprises and a 41% estimated miss probability.

What Douglas Elliman, Inc. hinges on

Over the next few quarters, the thesis hinges on sustaining revenue growth and positive operating cash flow while management continues expense discipline and geographic expansion. Fed rate cuts and stronger results from real estate peers could ease the sector headwind; a guidance cut would weaken the setup.

Bottom line

For the next 1 to 3 years, DOUG remains a watch-state, higher-risk thesis: cash-flow progress is real, but revenue volatility, losses, and sector weakness still matter. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.